vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and PATHWARD FINANCIAL, INC. (CASH). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($263.6M vs $173.1M, roughly 1.5× PATHWARD FINANCIAL, INC.). PATHWARD FINANCIAL, INC. runs the higher net margin — 20.3% vs 14.9%, a 5.4% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (9.8% vs -0.2%). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (4.9% CAGR vs -18.0%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.
BCPC vs CASH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $173.1M |
| Net Profit | $39.2M | $35.2M |
| Gross Margin | 35.6% | — |
| Operating Margin | 19.8% | 24.6% |
| Net Margin | 14.9% | 20.3% |
| Revenue YoY | 9.8% | -0.2% |
| Net Profit YoY | 16.8% | 11.9% |
| EPS (diluted) | $1.21 | $1.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $173.1M | ||
| Q3 25 | $267.6M | $186.7M | ||
| Q2 25 | $255.5M | $195.8M | ||
| Q1 25 | $250.5M | $274.8M | ||
| Q4 24 | $240.0M | $182.6M | ||
| Q3 24 | $239.9M | $179.5M | ||
| Q2 24 | $234.1M | $188.6M | ||
| Q1 24 | $239.7M | $257.6M |
| Q4 25 | $39.2M | $35.2M | ||
| Q3 25 | $40.3M | $38.8M | ||
| Q2 25 | $38.3M | $42.1M | ||
| Q1 25 | $37.1M | $75.0M | ||
| Q4 24 | $33.6M | $30.0M | ||
| Q3 24 | $33.8M | $33.5M | ||
| Q2 24 | $32.1M | $44.9M | ||
| Q1 24 | $29.0M | $69.9M |
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 34.0% | — |
| Q4 25 | 19.8% | 24.6% | ||
| Q3 25 | 20.4% | 25.9% | ||
| Q2 25 | 20.1% | 24.1% | ||
| Q1 25 | 20.4% | 33.2% | ||
| Q4 24 | 19.8% | 19.8% | ||
| Q3 24 | 20.0% | 20.9% | ||
| Q2 24 | 19.6% | 27.1% | ||
| Q1 24 | 17.4% | 33.8% |
| Q4 25 | 14.9% | 20.3% | ||
| Q3 25 | 15.1% | 20.8% | ||
| Q2 25 | 15.0% | 21.5% | ||
| Q1 25 | 14.8% | 27.3% | ||
| Q4 24 | 14.0% | 16.4% | ||
| Q3 24 | 14.1% | 18.7% | ||
| Q2 24 | 13.7% | 23.8% | ||
| Q1 24 | 12.1% | 27.1% |
| Q4 25 | $1.21 | $1.57 | ||
| Q3 25 | $1.24 | $1.69 | ||
| Q2 25 | $1.17 | $1.81 | ||
| Q1 25 | $1.13 | $3.14 | ||
| Q4 24 | $1.03 | $1.23 | ||
| Q3 24 | $1.03 | $1.34 | ||
| Q2 24 | $0.98 | $1.78 | ||
| Q1 24 | $0.89 | $2.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $331.2M |
| Total DebtLower is stronger | — | $33.5M |
| Stockholders' EquityBook value | $1.3B | $854.5M |
| Total Assets | $1.7B | $7.6B |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $331.2M | ||
| Q3 25 | $65.1M | $120.6M | ||
| Q2 25 | $65.4M | $258.3M | ||
| Q1 25 | $49.9M | $254.2M | ||
| Q4 24 | $49.5M | $597.4M | ||
| Q3 24 | $73.7M | $158.3M | ||
| Q2 24 | $63.7M | $298.9M | ||
| Q1 24 | $60.3M | $347.9M |
| Q4 25 | — | $33.5M | ||
| Q3 25 | — | $33.5M | ||
| Q2 25 | — | $33.4M | ||
| Q1 25 | — | $33.4M | ||
| Q4 24 | — | $33.4M | ||
| Q3 24 | — | $33.4M | ||
| Q2 24 | — | $33.3M | ||
| Q1 24 | — | $33.4M |
| Q4 25 | $1.3B | $854.5M | ||
| Q3 25 | $1.3B | $858.0M | ||
| Q2 25 | $1.3B | $819.0M | ||
| Q1 25 | $1.2B | $814.7M | ||
| Q4 24 | $1.1B | $758.3M | ||
| Q3 24 | $1.2B | $822.5M | ||
| Q2 24 | $1.1B | $748.4M | ||
| Q1 24 | $1.1B | $719.5M |
| Q4 25 | $1.7B | $7.6B | ||
| Q3 25 | $1.7B | $7.2B | ||
| Q2 25 | $1.7B | $7.2B | ||
| Q1 25 | $1.6B | $7.0B | ||
| Q4 24 | $1.6B | $7.6B | ||
| Q3 24 | $1.6B | $7.5B | ||
| Q2 24 | $1.6B | $7.5B | ||
| Q1 24 | $1.6B | $7.4B |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.04× | ||
| Q1 25 | — | 0.04× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | 0.05× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $108.3M |
| Free Cash FlowOCF − Capex | — | $104.1M |
| FCF MarginFCF / Revenue | — | 60.1% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | 1.72× | 3.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $616.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $108.3M | ||
| Q3 25 | $65.6M | $303.7M | ||
| Q2 25 | $47.3M | $30.4M | ||
| Q1 25 | $36.5M | $188.3M | ||
| Q4 24 | $52.3M | $-71.7M | ||
| Q3 24 | $51.3M | $143.1M | ||
| Q2 24 | $45.0M | $113.2M | ||
| Q1 24 | $33.4M | $203.0M |
| Q4 25 | — | $104.1M | ||
| Q3 25 | — | $300.3M | ||
| Q2 25 | — | $27.7M | ||
| Q1 25 | — | $184.7M | ||
| Q4 24 | — | $-73.8M | ||
| Q3 24 | — | $138.8M | ||
| Q2 24 | — | $111.0M | ||
| Q1 24 | — | $201.3M |
| Q4 25 | — | 60.1% | ||
| Q3 25 | — | 160.9% | ||
| Q2 25 | — | 14.1% | ||
| Q1 25 | — | 67.2% | ||
| Q4 24 | — | -40.4% | ||
| Q3 24 | — | 77.3% | ||
| Q2 24 | — | 58.8% | ||
| Q1 24 | — | 78.1% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 0.7% |
| Q4 25 | 1.72× | 3.08× | ||
| Q3 25 | 1.63× | 7.83× | ||
| Q2 25 | 1.23× | 0.72× | ||
| Q1 25 | 0.98× | 2.51× | ||
| Q4 24 | 1.56× | -2.39× | ||
| Q3 24 | 1.52× | 4.27× | ||
| Q2 24 | 1.40× | 2.52× | ||
| Q1 24 | 1.15× | 2.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
CASH
| Consumer | $103.0M | 59% |
| Payment Card And Deposit Fees | $30.1M | 17% |
| Other | $24.2M | 14% |
| Rental Income | $11.6M | 7% |
| Commercial | $4.2M | 2% |
